These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative effects of nicorandil and nitroglycerin on tracheal and vascular smooth muscle in the dog, in vivo and in vitro. Nakamura Y, Shiraki Y, Nabata H, Sakai K. Jpn J Pharmacol; 1984 Mar; 34(3):269-76. PubMed ID: 6233439 [Abstract] [Full Text] [Related]
6. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil. Ueno A, Bergamaschi M, Gromo G, Nonaka K, Mizrahi J. J Cardiovasc Pharmacol; 1995 Mar; 26 Suppl 4():S13-20. PubMed ID: 8839221 [Abstract] [Full Text] [Related]
7. Effects of long-term nicorandil application on coronary arteries in conscious dogs. Huckstorf C, Bassenge E. J Cardiovasc Pharmacol; 1992 Mar; 20 Suppl 3():S29-33. PubMed ID: 1282173 [Abstract] [Full Text] [Related]
8. Nitrate tolerance induced by nicorandil or nitroglycerin is associated with minimal loss of nicorandil vasodilator activity. Henry PJ, Horowitz JD, Louis WJ. J Cardiovasc Pharmacol; 1990 Mar; 15(3):365-70. PubMed ID: 1691358 [Abstract] [Full Text] [Related]
9. Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. Noguchi K, Matsuzaki T, Ojiri Y, Koyama T, Nakasone J, Sakanashi M. Fundam Clin Pharmacol; 1998 Mar; 12(3):270-8. PubMed ID: 9646059 [Abstract] [Full Text] [Related]
15. Comparisons of the effects of nicorandil, pinacidil, nicardipine and nitroglycerin on coronary vessels in the conscious dog: role of the endothelium. Ghaleh B, Dubois-Randé JL, Hittinger L, Giudicelli JF, Berdeaux A. Br J Pharmacol; 1995 Jan; 114(2):496-502. PubMed ID: 7881748 [Abstract] [Full Text] [Related]
16. Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs. Lamping KA, Gross GJ. J Cardiovasc Pharmacol; 1984 Jan; 6(4):601-8. PubMed ID: 6206313 [Abstract] [Full Text] [Related]
17. Tolerance to the increase in coronary blood flow induced by KRN2391. Kaneta S, Jinno Y, Harada K, Fukushima H, Ogawa N. Arch Int Pharmacodyn Ther; 1992 Jan; 318():21-35. PubMed ID: 1463369 [Abstract] [Full Text] [Related]
18. Coronary and systemic hemodynamic effects of the putative nitric oxide donor, FK 409, in comparison with nitroglycerin in conscious and anesthetized dogs. Drieu la Rochelle C, Lainée P, Grosset A, O'Connor SE. J Cardiovasc Pharmacol; 1995 Oct; 26(4):555-63. PubMed ID: 8569215 [Abstract] [Full Text] [Related]
19. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo. Kamijo T, Iwai T, Haruta K, Takeda K. Arch Int Pharmacodyn Ther; 1996 Oct; 331(3):273-84. PubMed ID: 9124999 [Abstract] [Full Text] [Related]
20. Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation. Nishikawa Y, Kanki H, Ogawa S. J Cardiovasc Pharmacol; 1998 Jul; 32(1):21-8. PubMed ID: 9676716 [Abstract] [Full Text] [Related] Page: [Next] [New Search]